<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for AZN</title>
    <link />
    <description>Headlines for AstraZeneca plc (ADR)</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>AstraZeneca: A Dividend Payer With An Attractive Growth Prospect</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1446851-astrazeneca-a-dividend-payer-with-an-attractive-growth-prospect.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 20 May 2013 09:59:00 GMT</pubDate>
    </item>
    <item>
      <title>Statin Users May Have a Reason to Rejoice After This Data</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/19/statin-users-may-have-a-reason-to-rejoice-after-th/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sun, 19 May 2013 12:05:00 GMT</pubDate>
    </item>
    <item>
      <title>U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/trading-ideas/long-ideas/13/05/3601714/u-s-steel-genomic-health-and-other-stocks-insiders-are-buying.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Sat, 18 May 2013 15:54:32 GMT</pubDate>
    </item>
    <item>
      <title>1 Giant Leap for MannKind</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/18/1-giant-leap-for-mannkind/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 18 May 2013 12:45:00 GMT</pubDate>
    </item>
    <item>
      <title>Pick Your Poison: Overweight or High Cholesterol</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/18/pick-your-poison-overweight-or-high-cholesterol/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 18 May 2013 11:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Cheerleaders: Look Beyond Pharma For Jobs</title>
      <link>http://www.fool.com/news/xt/ycharts/ycharts.com/analysis/story/cheerleaders_look_beyond_pharma_for_jobs.aspx?source=itxwebtxt0000015</link>
      <author>YCharts</author>
      <pubDate>Thu, 16 May 2013 21:05:16 GMT</pubDate>
    </item>
    <item>
      <title>Good News for Roche's Tarceva  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99616/good-news-for-roches-tarceva.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 16 May 2013 18:30:01 GMT</pubDate>
    </item>
    <item>
      <title>Is AstraZeneca Gearing Up for a Shopping Spree?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/15/is-astrazeneca-gearing-up-for-a-shopping-spree/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 15 May 2013 10:06:00 GMT</pubDate>
    </item>
    <item>
      <title>Array Biopharma: Measuring The Strength Of This Small-Cap Pharma Stock</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1435851-array-biopharma-measuring-the-strength-of-this-small-cap-pharma-stock.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 15 May 2013 05:45:38 GMT</pubDate>
    </item>
    <item>
      <title>A Closer Look at AstraZeneca's Dividend Potential</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/14/a-closer-look-at-astrazenecas-dividend-potential/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 14 May 2013 11:10:00 GMT</pubDate>
    </item>
    <item>
      <title>What To Buy And Sell In Your High-Yield Portfolio</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1432691-what-to-buy-and-sell-in-your-high-yield-portfolio.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 14 May 2013 07:49:33 GMT</pubDate>
    </item>
    <item>
      <title>Big Pharma's Biggest Losers</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/13/big-pharmas-biggest-losers/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 13 May 2013 14:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Part 2: Will Array BioPharma Become A Late-Stage Biopharmaceutical Company?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1428191-part-2-will-array-biopharma-become-a-late-stage-biopharmaceutical-company.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 12 May 2013 18:21:21 GMT</pubDate>
    </item>
    <item>
      <title>Part 1: Will Array BioPharma Become A Late-Stage Biopharmaceutical Company?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1428181-part-1-will-array-biopharma-become-a-late-stage-biopharmaceutical-company.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 12 May 2013 18:06:09 GMT</pubDate>
    </item>
    <item>
      <title>Tackling Cancer: Endometrial Cancer's Biggest Current and Upcoming Players</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/11/tackling-cancer-endometrial-cancers-biggest-curren/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 11 May 2013 15:00:00 GMT</pubDate>
    </item>
    <item>
      <title>“Marketing Without Innovation”: a Merck Story</title>
      <link>http://www.fool.com/news/xt/ycharts/ycharts.com/analysis/story/marketing_without_innovation_a_merck_story.aspx?source=itxwebtxt0000015</link>
      <author>YCharts</author>
      <pubDate>Fri, 10 May 2013 15:42:16 GMT</pubDate>
    </item>
    <item>
      <title>No Fat in This Drug Launch</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/10/no-fat-in-this-drug-launch/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 10 May 2013 14:21:00 GMT</pubDate>
    </item>
    <item>
      <title>Wider-than-Expected Loss at Optimer - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99140/wider-than-expected-loss-at-optimer.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 10 May 2013 12:10:01 GMT</pubDate>
    </item>
    <item>
      <title>Pharma’s Failure: Drug Spending Finally Declines</title>
      <link>http://www.fool.com/news/xt/ycharts/ycharts.com/analysis/story/pharmas_failure_drug_spending_finally_declines.aspx?source=itxwebtxt0000015</link>
      <author>YCharts</author>
      <pubDate>Thu, 09 May 2013 22:07:42 GMT</pubDate>
    </item>
    <item>
      <title>Cellceutix Corporation: The Next Generation Of Cancer Treatment Has Arrived</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1422381-cellceutix-corporation-the-next-generation-of-cancer-treatment-has-arrived.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 09 May 2013 22:02:42 GMT</pubDate>
    </item>
  </channel>
</rss>
